Consolidated Balance Sheets - USD ($)	Sep. 30, 2022	Sep. 30, 2021
Current Assets:
Cash and cash equivalents	$ 41,711,690	$ 70,072,946
Prepaid expenses	2,852,580	2,741,404
Total Current Assets	44,564,270	72,814,350
Property and equipment, net	4,100	7,023
Operating lease right-of-use asset, net	646,074	822,828
Other Assets:
Deposits	38,062	38,062
In-process research and development	59,400,000	59,400,000
Goodwill	9,346,796	9,346,796
Total Other Assets	68,784,858	68,784,858
Total Assets	113,999,302	142,429,059
Current Liabilities:
Accounts payable	1,165,378	1,277,095
Accrued expenses	1,405,394	621,960
Accrued compensation	1,762,251	1,906,000
Operating lease liability	196,989	177,237
Total Current Liabilities	4,530,012	3,982,292
Deferred tax liability	5,561,800	4,985,800
Operating lease liability – non current	481,245	678,234
Total Liabilities	10,573,057	9,646,326
Commitments and Contingencies
Stockholders’ Equity:
Preferred stock - $0.001 par value; 10,000,000 shares authorized; no shares issued and outstanding
Common stock - $0.001 par value; 400,000,000 shares authorized; 146,211,130 and 145,979,429 shares issued and outstanding at September 30, 2022 and 2021, respectively	146,211	145,979
Additional paid-in capital	232,368,121	228,084,195
Accumulated deficit	(129,688,467)	(96,047,821)
Total Citius Pharmaceuticals, Inc. Stockholders’ Equity	102,825,865	132,182,353
Non-controlling interest	600,380	600,380
Total Equity	103,426,245	132,782,733
Total Liabilities and Equity	$ 113,999,302	$ 142,429,059

Amount of in process research and development.

No definition available.

Name:	ctxr_InProcessResearchAndDevelopment
Namespace Prefix:	ctxr_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).